Wave Life Sciences WVE
NASDAQ WVE
$3.70 +0.06 (+1.65%)
At close: Sep 30, 2026 · 4:00 PM EDT

Wave Life Sciences (WVE) Current Deferred Revenue (2014 - 2026)

Updated

Wave Life Sciences (WVE) posted Current Deferred Revenue of $8.7 million for Q2 2026, down 83.1% from $51.58 million a year earlier and down 7.4% from the prior quarter.

Analysis

Wave Life Sciences (WVE) Current Deferred Revenue (2014 - 2026) Analysis & Trends

At the end of FY2025, Wave Life Sciences' Current Deferred Revenue came in at $44.44 million, down 32.6% from FY2024.

  • Annual Current Deferred Revenue shows a five-year compound annual growth rate of -13.5% (FY2020 to FY2025).
  • In prior years, Wave Life Sciences' Current Deferred Revenue was $65.97 million in FY2024 (-56.0%), $150.06 million in FY2023 (+375.5%), $31.56 million in FY2022 (-14.9%) and $37.1 million in FY2021 (-59.5%).
  • The Q2 2026 figure stands as the lowest quarterly Current Deferred Revenue since Q1 2018.
  • On a year-over-year basis, Current Deferred Revenue has declined in each of the last seven quarters, with an average decline of 43.0% over the last eight quarters.
  • The strongest year-over-year quarter for Current Deferred Revenue in the past five years was Q4 2023, with growth of 375.5%; the weakest was Q3 2021, with a decline of 89.9%.
  • According to Business Quant data, Current Deferred Revenue for the three prior quarters was $9.4 million (Q1 2026), $44.44 million (Q4 2025) and $46.53 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Wave Life Sciences 715.13 Mn -995.77 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.70 Mn
Mar 31, 2026 9.40 Mn
Dec 31, 2025 44.44 Mn
Sep 30, 2025 46.53 Mn
Jun 30, 2025 51.58 Mn
Mar 31, 2025 57.31 Mn
Dec 31, 2024 65.97 Mn
Sep 30, 2024 135.91 Mn
Jun 30, 2024 137.14 Mn
Mar 31, 2024 140.59 Mn
Dec 31, 2023 150.06 Mn
Sep 30, 2023 68.25 Mn
Jun 30, 2023 111.13 Mn
Mar 31, 2023 106.96 Mn
Dec 31, 2022 31.56 Mn
Sep 30, 2022 32.34 Mn
Jun 30, 2022 37.47 Mn
Mar 31, 2022 36.43 Mn
Dec 31, 2021 37.10 Mn
Sep 30, 2021 8.74 Mn
API Access

Wave Life Sciences Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=WVE&period=max&api_key=YOUR_API_KEY